Cite

HARVARD Citation

    Zheng, Y. et al. (2021). Real-World Clinical and Economic Outcomes in Selected Immune-Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors. Oncologist. pp. e2002-e2012. [Online]. 
  
Back to record